Froma Oberman

703 total citations
17 papers, 574 citations indexed

About

Froma Oberman is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Froma Oberman has authored 17 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Genetics. Recurrent topics in Froma Oberman's work include RNA Research and Splicing (12 papers), RNA modifications and cancer (7 papers) and Cancer-related molecular mechanisms research (4 papers). Froma Oberman is often cited by papers focused on RNA Research and Splicing (12 papers), RNA modifications and cancer (7 papers) and Cancer-related molecular mechanisms research (4 papers). Froma Oberman collaborates with scholars based in Israel, United States and United Kingdom. Froma Oberman's co-authors include Joel K. Yisraeli, S Schwartz, Nancy Standart, Anna Git, Karina Yaniv, Amos Panet, Daniel H. Wreschner, Christine A. Kelley, Eli Pikarsky and Samuel Salzberg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Genes & Development.

In The Last Decade

Froma Oberman

16 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Froma Oberman Israel 12 509 106 56 53 50 17 574
Claudia Reinke Germany 8 443 0.9× 149 1.4× 51 0.9× 38 0.7× 34 0.7× 8 532
Sarah J. Goodfellow United Kingdom 9 469 0.9× 70 0.7× 29 0.5× 16 0.3× 46 0.9× 11 516
Catherine Zanibellato France 8 337 0.7× 72 0.7× 84 1.5× 41 0.8× 31 0.6× 9 411
Isabelle Barlat France 10 449 0.9× 83 0.8× 84 1.5× 52 1.0× 43 0.9× 10 539
Cheryl Li De Hoyos United States 13 764 1.5× 99 0.9× 22 0.4× 41 0.8× 41 0.8× 15 835
Barbara Hopfgartner Austria 2 341 0.7× 85 0.8× 40 0.7× 62 1.2× 36 0.7× 2 451
B. Bugler France 8 624 1.2× 51 0.5× 140 2.5× 40 0.8× 85 1.7× 11 713
Tea Blom Finland 11 199 0.4× 63 0.6× 62 1.1× 22 0.4× 44 0.9× 11 393
Christel Boutonnet France 6 373 0.7× 48 0.5× 99 1.8× 45 0.8× 34 0.7× 7 427
Ken Fujimura United States 13 593 1.2× 62 0.6× 135 2.4× 51 1.0× 19 0.4× 20 697

Countries citing papers authored by Froma Oberman

Since Specialization
Citations

This map shows the geographic impact of Froma Oberman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Froma Oberman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Froma Oberman more than expected).

Fields of papers citing papers by Froma Oberman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Froma Oberman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Froma Oberman. The network helps show where Froma Oberman may publish in the future.

Co-authorship network of co-authors of Froma Oberman

This figure shows the co-authorship network connecting the top 25 collaborators of Froma Oberman. A scholar is included among the top collaborators of Froma Oberman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Froma Oberman. Froma Oberman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Oberman, Froma, Myriam Grunewald, Amandeep Singh, et al.. (2025). AVJ16 inhibits lung carcinoma by targeting IGF2BP1. Oncogene. 44(35). 3239–3254.
2.
Singh, Amandeep, Vikash Singh, Froma Oberman, et al.. (2023). Development of a specific and potent IGF2BP1 inhibitor: A promising therapeutic agent for IGF2BP1-expressing cancers. European Journal of Medicinal Chemistry. 263. 115940–115940. 14 indexed citations
3.
Oberman, Froma, Yuval Cinnamon, Mordechai Golomb, et al.. (2023). RNA binding protein IGF2BP2 expression is induced by stress in the heart and mediates dilated cardiomyopathy. Communications Biology. 6(1). 1229–1229. 8 indexed citations
4.
Oberman, Froma, Khriesto A. Shurrush, Nicolas Germain, et al.. (2021). Small molecule inhibitor of Igf2bp1 represses Kras and a pro-oncogenic phenotype in cancer cells. RNA Biology. 19(1). 26–43. 52 indexed citations
5.
Mishalian, Inbal, et al.. (2019). VICKZ1 enhances tumor progression and metastasis in lung adenocarcinomas in mice. Oncogene. 38(21). 4169–4181. 22 indexed citations
6.
Shoshkes-Carmel, Michal, Nitza Kahane, Froma Oberman, et al.. (2015). A Novel Role for VICKZ Proteins in Maintaining Epithelial Integrity during Embryogenesis. PLoS ONE. 10(8). e0136408–e0136408. 8 indexed citations
7.
Oberman, Froma, et al.. (2015). Localization of cofilin mRNA to the leading edge of migrating cells promotes directed cell migration. Journal of Cell Science. 128(10). 1922–1933. 13 indexed citations
8.
Vainer, Gilad W., Alon J. Pikarsky, Shailesh M. Shenoy, et al.. (2008). A role for VICKZ proteins in the progression of colorectal carcinomas: regulating lamellipodia formation. The Journal of Pathology. 215(4). 445–456. 35 indexed citations
9.
Oberman, Froma, et al.. (2007). VICKZ proteins mediate cell migration via their RNA binding activity. RNA. 13(9). 1558–1569. 27 indexed citations
10.
Yaniv, Karina, Froma Oberman, Uta Wolke, et al.. (1999). Vg1 RBP intracellular distribution and evolutionarily conserved expression at multiple stages during development. Mechanisms of Development. 88(1). 101–106. 52 indexed citations
11.
Git, Anna, Froma Oberman, Karina Yaniv, et al.. (1998). RNA-binding protein conserved in both microtubule- and microfilament-based RNA localization. Genes & Development. 12(11). 1593–1598. 186 indexed citations
12.
Kelley, Christine A., Froma Oberman, Joel K. Yisraeli, & Robert Adelstein. (1995). A Xenopus Nonmuscle Myosin Heavy Chain Isoform Is Phosphorylated by Cyclin-p34cdc2 Kinase during Meiosis. Journal of Biological Chemistry. 270(3). 1395–1401. 23 indexed citations
13.
Oberman, Froma & Joel K. Yisraeli. (1995). Technical tip. Trends in Genetics. 11(3). 83–84. 9 indexed citations
14.
Schwartz, S, et al.. (1992). A 69-kDa RNA-binding protein from Xenopus oocytes recognizes a common motif in two vegetally localized maternal mRNAs.. Proceedings of the National Academy of Sciences. 89(24). 11895–11899. 74 indexed citations
15.
Oberman, Froma & Amos Panet. (1989). Characterization of the Early Steps of Herpes Simplex Virus Replication in Interferon-Treated Human Cells. Journal of Interferon Research. 9(5). 563–571. 23 indexed citations
16.
Salzberg, Samuel, Daniel H. Wreschner, Froma Oberman, Amos Panet, & Mary Bakhanashvili. (1983). Isolation and characterization of an interferon-resistant cell line deficient in the induction of (2'-5')oligoadenylate synthetase activity.. Molecular and Cellular Biology. 3(10). 1759–1765. 20 indexed citations
17.
Salzberg, Samuel, Daniel H. Wreschner, Froma Oberman, Amos Panet, & Mary Bakhanashvili. (1983). Isolation and Characterization of an Interferon-Resistant Cell Line Deficient in the Induction of (2′-5′)Oligoadenylate Synthetase Activity. Molecular and Cellular Biology. 3(10). 1759–1765. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026